Skip to main content
. 2025 Oct 22;14(6):1899–1914. doi: 10.1007/s40122-025-00784-w

Table 5.

Responder rates for improvement in only one of three efficacy parameters (chronic migraine)

Efficacy parameter combination Responder rate Patients (n)

MIDAS, negative

HIT-6, negative

Migraine days, positive

6.8% 15

MIDAS, positive

HIT-6, negative

Migraine days, negative

5.9% 13

MIDAS, negative

HIT-6, positive

Migraine days, negative

9.6% 21